NAMPT inhibition is a novel synthetic lethal therapeutic approach exploiting nuclear–mitochondrial crosstalk in ERCC1-deficient populations. (December 2016) - Touat, M.; Olaussen, K.; Sourisseau, T.; Friboulet, L.; Dorvault, N.; Enot, D.; Bigot, L.; Pontoizeau, C.; Mardakheh, F.; Thompson, A.; Bouillaud, F.; Ricchetti, M.; et al.